Skip to content

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.

Randomized controlled trial · JAMA · 2018. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 29318278

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.

Atri A, Frölich L, Ballard C et al.
JAMA · 2018

PubMed ID
29318278
Record checked

Linked publication notices

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.